Trials / Conditions / Generalized Arterial Calcification of Infancy
Generalized Arterial Calcification of Infancy
6 registered clinical trials studyying Generalized Arterial Calcification of Infancy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency NCT06046820 | Inozyme Pharma | Phase 3 |
| Recruiting | The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 D NCT05734196 | Inozyme Pharma | Phase 1 |
| Completed | Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency NCT05050669 | Inozyme Pharma | — |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE NCT05030831 | Inozyme Pharma | Phase 1 / Phase 2 |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency NCT04686175 | Inozyme Pharma | Phase 1 / Phase 2 |
| Completed | Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphate NCT03478839 | National Human Genome Research Institute (NHGRI) | — |